These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 3370071)
1. Pharmacokinetics of an active cadralazine metabolite in plasma and blood vessels of spontaneously hypertensive rats. Terauchi Y; Watari S; Ishikawa S; Takeyama K; Sekine Y; Hashimoto M; Hayashi T Arzneimittelforschung; 1988 Feb; 38(2):237-9. PubMed ID: 3370071 [TBL] [Abstract][Full Text] [Related]
2. Antihypertensive activity of cadralazine in experimental hypertensive rats. Takeyama K; Ikeno A; Minato H; Fukuya F; Nishimura S; Hosoki K; Kadokawa T Arch Int Pharmacodyn Ther; 1988; 291():163-74. PubMed ID: 3365060 [TBL] [Abstract][Full Text] [Related]
3. [Influence of acetylation phenotype on the pharmacokinetics and pharmacodynamics data of cadralazine in normotensive subjects]. Brunel P; Lecaillon JB; Imhof P; Menard J Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1257-60. PubMed ID: 2510657 [TBL] [Abstract][Full Text] [Related]
4. Determination of ISF-2405, an active metabolite of cadralazine, in plasma and tissues by radioimmunoassay. Terauchi Y; Watari S; Ishikawa S; Nakao M; Negoro T; Kagemoto A; Sekine Y; Hashimoto M J Pharmacobiodyn; 1987 Dec; 10(12):758-66. PubMed ID: 3451960 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of cadralazine in hypertensive patients. Leonetti G; Parini J; Visconti M; Gradnik R Eur J Drug Metab Pharmacokinet; 1988; 13(4):295-300. PubMed ID: 3243325 [TBL] [Abstract][Full Text] [Related]
6. Effects of cadralazine on contractions induced by norepinephrine, serotonin, angiotensin II and K+ in rabbit aortic and renal arterial strips. Higashio T; Kuroda K Arzneimittelforschung; 1988 Mar; 38(3):341-6. PubMed ID: 3382457 [TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of cadralazine in hexamethonium treated and non-treated anesthetized dogs. Higashio T; Tsuji Y; Nakao K; Sakaguchi S; Tanaka M Arzneimittelforschung; 1988 Mar; 38(3):350-8. PubMed ID: 3382459 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of enantiomers of pimobendan in patients with dilated cardiomyopathy and congestive heart failure after single and repeated oral dosing. Chu KM; Shieh SM; Hu OY Clin Pharmacol Ther; 1995 Jun; 57(6):610-21. PubMed ID: 7781260 [TBL] [Abstract][Full Text] [Related]
9. Hemodynamic profile of the antihypertensive vasodilator cadralazine in conscious dogs. Dorigotti L; Ferni G; Lombroso M; Semeraro C Arzneimittelforschung; 1984; 34(9):984-7. PubMed ID: 6542375 [TBL] [Abstract][Full Text] [Related]
10. Human pharmacokinetics of cadralazine: a new vasodilator. Hauffe SA; Dubois JP; Imhof PR Eur J Drug Metab Pharmacokinet; 1985; 10(3):217-23. PubMed ID: 4085523 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and bioavailability of bemoradan, a long-acting inodilator in healthy males. Huang SM; Brusser L; Chien SC; Simon D; Smith IL; Abrams LS; Lasseter K Int J Clin Pharmacol Ther; 1994 Feb; 32(2):62-4. PubMed ID: 8004360 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of cadralazine and its hydrazino-metabolite in patients with renal impairment after repeated administration of 5 mg once daily. Marichal JF; Brunel P; Lecaillon JB; Godbillon J; Faller B; Brignon P; Ménard J Eur J Drug Metab Pharmacokinet; 1992; 17(3):213-20. PubMed ID: 1490491 [TBL] [Abstract][Full Text] [Related]
13. Tissue distribution of antihypertensive dipeptide, Val-Tyr, after its single oral administration to spontaneously hypertensive rats. Matsui T; Imamura M; Oka H; Osajima K; Kimoto K; Kawasaki T; Matsumoto K J Pept Sci; 2004 Sep; 10(9):535-45. PubMed ID: 15473262 [TBL] [Abstract][Full Text] [Related]
14. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats. Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071 [TBL] [Abstract][Full Text] [Related]
15. [Effects of nifedipine controlled release on blood pressure and heart rate of spontaneously hypertensive rats. Comparison with nifedipine standard and with amlodipine]. Di Filippo C; Lampa E; Forgione A; Capuano A; Rossi F; D'Amico M Ital Heart J Suppl; 2005 May; 6(5):285-90. PubMed ID: 15934425 [TBL] [Abstract][Full Text] [Related]
16. Effects of cadralazine on contractions induced by Ca2+ and norepinephrine in isolated rabbit aortic strips. Higashio T; Kuroda K Arzneimittelforschung; 1988 Mar; 38(3):346-9. PubMed ID: 3382458 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of the new antihypertensive agent nipradilol in rats. 2nd communication: A single oral administration of [14C]nipradilol to spontaneously hypertensive rats. Kimata H; Kabuto S; Yonemitsu M; Koide T; Nakao H; Suzuki J Arzneimittelforschung; 1985; 35(11):1680-4. PubMed ID: 4091870 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological studies on cadralazine: a new antihypertensive vasodilator drug. Semeraro C; Dorigotti L; Banfi S; Carpi C J Cardiovasc Pharmacol; 1981; 3(3):455-67. PubMed ID: 6168827 [TBL] [Abstract][Full Text] [Related]
19. Influence of acetylator status on the haemodynamic effects and pharmacokinetics of cadralazine in healthy subjects. Brunel P; Lecaillon JB; Guyene TT; Imhof P; Ménard J Br J Clin Pharmacol; 1990 May; 29(5):503-9. PubMed ID: 2190629 [TBL] [Abstract][Full Text] [Related]